Financhill
Back

Phreesia Quote, Financials, Valuation and Earnings

Phreesia Price Quote

$18.50
-0.02 (-0.27%)
(Updated: November 21, 2024 at 5:20 AM ET)

Phreesia Key Stats

Sell
43
Phreesia (PHR) is a Sell

Day range:
$17.78 - $18.57
52-week range:
$14.55 - $29.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.72
P/B ratio:
4.32%

Volume:
650.7K
Avg. volume:
418.6K
1-year change:
15.82%
Market cap:
$1.1B
Revenue:
$356.3M
EPS:
$-1.8

How Much Does Phreesia Make?

  • How Much Are Phreesia's Sales Annually?
    PHR Revenues are $356.3M
  • How Much Profit Does Phreesia's Make A Year?
    PHR net income is -$136.9M

Is Phreesia Growing As A Company?

  • What Is Phreesia's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is Phreesia's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Phreesia Stock Price Performance

  • Did Phreesia Stock Go Up Last Month?
    Phreesia share price went down by -6.46% last month
  • Did PHR's Share Price Rise Over The Last Year?
    PHR share price rose by 15.82% over the past 1 year

What Is Phreesia 52-Week High & Low?

  • What Is Phreesia’s 52-Week High Share Price?
    Phreesia has traded as high as $29.16 over the past 52 weeks
  • What Is Phreesia’s 52-Week Low Share Price?
    Phreesia has traded as low as $14.55 over the past 52 weeks

Phreesia Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Phreesia?

  • How Much Debt Does Phreesia Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Phreesia Have?
    Cash and short term investments quarterly total is $81.8M
  • What Is Phreesia’s Book Value Per Share?
    Book value per share is 4.36

Is Phreesia Cash Flow Positive?

  • What Is PHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $952K
  • What Is Phreesia’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$10.1M
  • What Is Phreesia’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.7M

Phreesia Return On Invested Capital

  • Is Management Doing A Good Job?
    PHR return on invested capital is -39.49%
  • What Is Phreesia Return On Assets?
    ROA measures how assets are converting to revenues and is -27.57%
  • What Is PHR Return On Equity?
    ROE is a measure of profitability and is -39.59%

Phreesia Earnings Date & Stock Price

  • What Is Phreesia's Stock Price Today?
    A single share of PHR can be purchased today for 18.52
  • What Is Phreesia’s Stock Symbol?
    Phreesia trades on the nyse under the ticker symbol: PHR
  • When Is Phreesia’s Next Earnings Date?
    The next quarterly earnings date for Phreesia is scheduled on December 9, 2024
  • When Is PHR's next ex-dividend date?
    Phreesia's next ex-dividend date is November 21, 2024
  • How To Buy Phreesia Stock?
    You can buy Phreesia shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Phreesia Competitors

  • Who Are Phreesia's Competitors?
    Below is a list of companies who compete with Phreesia or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • P3 Health Partners Inc (PIII)

Phreesia Dividend Yield

  • What Is PHR Dividend Yield?
    Phreesia’s dividend yield currently is 0%
  • What Is Phreesia’s Payout Ratio?
    Phreesia’s payout ratio is 0%
  • When Did Phreesia Last Pay A Dividend?
    The latest dividend pay date is November 21, 2024
  • What Is Phreesia’s Dividend Per Share?
    Phreesia pays a dividend of $0.00 per share

Phreesia Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 51.65%
Revenue: 18.97% 0.47%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 29.33
Upside from Last Price: 58.39%

Major Shareholders

  • How many PHR shares are owned by institutional investors?
    106M PHR shares are owned by institutional investors
  • How many PHR shares are owned by insiders?
    3.4M PHR shares are owned by insiders